CytoSorbents Appoints Ronald Berger as Interim Chief Financial Officer
MONMOUTH JUNCTION, N.J., Feb. 8, 2013 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care focused company using blood purification to treat life-threatening illnesses, today announced the appointment of Mr. Ronald Berger as Interim Chief Financial Officer. Mr. Berger replaces Mr. Thomas Bocchino, Chief Financial Officer, who has had to reduce the number of hours he can commit to the Company due to personal reasons, but will continue to assist the Company in a part-time capacity, as a permanent solution is sought. The change takes effect immediately.
Thomas Bocchino stated, "This is an exciting time for CytoSorbents and I am glad to have the ability to continue to work with the Company on a part-time basis."
Dr. Phillip Chan, Chief Executive Officer of CytoSorbents, commented, "Ron and Tom have worked closely together for the past several months and make a good team. Ron has done an outstanding job as Interim CFO in the past, and we expect a smooth transition and continuation of the work we have set in place. We have the best wishes for Tom and look forward to continuing to work with him as we put the pieces together for our success."
Over more than 30 years, Mr. Berger has performed many roles in accounting and finance, including serving as Vice President of Finance and Administration of Quick Chek Corporation and Controller of Singer Supermarkets, a member of ShopRite Supermarkets. He is a certified public accountant experienced in treasury, finance and taxes. Mr. Berger has been Controller for the Company over the past nine years, previously served as Interim CFO, and has extensive experience in the public administration of the Company.